Vise Technologies’s Globus Medical GMED Stock Holding History

Vise Technologies’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	13,632 +5,163	+61%	+$439K	0.01%	760
2026 Q1	$739K	Hold	8,469	–	–	0.01%	693
2025 Q4	$739K	Buy	+8,469	New	+$643K	0.01%	698

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vise Technologies's GMED Position: Q2 2026 in Review

Vise Technologies increased its Globus Medical (GMED) stake by 61% in Q2 2026, buying an estimated $439K and bringing the position to 13,632 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #760.

Vise Technologies first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Vise Technologies held 13,632 shares of Globus Medical worth $1.08M as of Q2 2026.
Vise Technologies bought 5,163 Globus Medical shares in Q2 2026, an estimated $439K.
Globus Medical made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #760 holding.
Vise Technologies first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.